There could be progress on the cannabis legalization front in the next five years. Whether Tilray benefits from this will depend on a lot of factors. The company's outlook remains risky and uncertain.
Hosted on MSN1mon
Tilray Brands, Inc. (NASDAQ:TLRY) Q2 2025 Earnings Call TranscriptIn Italy, we are focused on increasing awareness of the Tilray Medical brand and our product portfolio, where we have market authorization for three medical cannabis extracts, as well as investing ...
One of the larger players on the pot market is Tilray Brands (NASDAQ: TLRY), and its difficult 2024 mirrored the woes of the cannabis sector in general. Let's do a flyby. Tilray's major story ...
One of the top cannabis stocks in the industry is Tilray Brands (TLRY-5.66%), and during that stretch, its valuation has crumbled, falling by a staggering 94%. The Canada-based company has been ...
Tilray’s Montauk Brewing secures a JetBlue partnership, making Surf Beer Golden Ale available on all flights. Tilray continues to expand its alcohol division, leveraging mainstream placements to ...
Cannabis stocks have largely generated abysmal returns during much of that time. Tilray Brands (NASDAQ: TLRY), a leader in the sector, is no exception. However, the company has made significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results